Biomaterials for Medical Applications--Trends and Opportunity Analysis (Technical Insights)

Trends and Technology Roadmapping

Regular Price: USD 4,950

Special Price USD 3,465

30% OFF

* Required Fields

Regular Price: USD 4,950

Special Price USD 3,465

PAY BY INVOICE

Be the first to review this product

This research service provides a strategic insight into the biomaterials for medical device industry. Starting off with a concise outlook on the technology capability and maturity, the service proceeds to profile the stakeholder and innovator activities with regard to product solutions, regulations, and challenge mitigation. Value chain Assessment and Technology Roadmap have been captured in detail. An analytical piece (AHP analysis) for technology benchmarking to prioritize biomaterial technologies completes the research study.

Table of Contents

Biomaterials for Medical Applications--Trends and Opportunity Analysis (Technical Insights), Executive SummaryResearch OverviewResearch SnapshotKey FindingsScope and MethodologyScopeMethodologyBiomaterials for Medical Applications--Trends and Opportunity Analysis (Technical Insights), Technology Capability and MaturityTechnology CapabilityTechnology Potential--Application PerspectiveTechnology TrendsTechnology MaturityDrivers and ChallengesTechnology Readiness LevelsBiomaterials for Medical Applications--Trends and Opportunity Analysis (Technical Insights), Industry Activities and Regulatory ScenarioIndustry ActivitiesResearch Activities New Product DevelopmentRegulatory Issues and Industry InitiativesRegulatory IssuesIndustry Initiatives and OpportunitiesBiomaterials for Medical Applications--Trends and Opportunity Analysis (Technical Insights), Stakeholder Analysis and Technology RoadmapStakeholder AnalysisValue Chain AssessmentStakeholders--Key FindingsBusiness Models and Technology RoadmapExisting Business ModelsTechnology RoadmapBiomaterials for Medical Applications--Trends and Opportunity Analysis (Technical Insights), Technology BenchmarkingAnalytical Hierarchy Process (AHP)--Prioritization of Biomaterial TechnologiesAHP--A GlimpseDefinition of CriteriaProcess Calculation and Final PrioritiesAHP Process and Computation--Level 0 and Level 1 CriteriaAHP Process and Computation AlternativesCalculation and Final PrioritiesBiomaterials for Medical Applications--Trends and Opportunity Analysis (Technical Insights), Patents and ContactsKey PatentsApplied PatentsIssued PatentsKey ContactsCorporatesResearch InstitutesBiomaterials for Medical Applications--Trends and Opportunity Analysis (Technical Insights), Decision Support DatabaseCritical Reference TablesTotal Healthcare Expenditure--World (2006 to 2016)Number Surgical Procedures for In Patients--United States (2004 to 2014)Number of Cochlear Implant Surgeries Performed - World (2004 to 2008) Number of Heart Transplant Surgeries Performed - World (2004 to 2008)Number of Kidney Transplant Surgeries Performed - World (2004 to 2008)




Keyword1

Keyword2

Keyword3

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.